Tokyo, Japan

Crysoptix Kk


USPTO Granted Patents = 17

% Expired Patents = 5.9


Forward Citations = 103

Loading Chart...
Loading Chart...

10 inventors (with patents filed for the assignee):

goldMedal Pavel Ivan Lazarev (5 out of 93 patents)

silverMedal Ellina Kharatiyan (5 out of 5 patents)

bronzeMedal Serguei Petrovich Palto (5 out of 5 patents)

4.  Tatyana Doutova (3 out of 3 patents)

5.  Elena N Sidorenko (3 out of 10 patents)

6.  Irina Kasianova (3 out of 3 patents)

7.  Valery S Kuzmin (3 out of 3 patents)

8.  Alexey Nokel (2 out of 5 patents)

9.  Darya Yurchenko (1 out of 1 patent)

10.  Arthur Geivandov (1 out of 1 patent)

11.  Pavel I Lazarev (0 patent)

12.  Valery Kuzmin (0 patent)

13.  Pavel I Lazarev (0 patent)


17 patents:

Company Overview
Crysoptix Kk is a Tokyo-based company specializing in advanced optical technologies and solutions. The organization focuses on the development and manufacturing of innovative optical components and systems, catering to various industries including telecommunications, medical devices, and consumer electronics. With a commitment to enhancing optical performance and efficiency, Crysoptix Kk leverages cutting-edge research to drive advancements in photonics and imaging technologies, positioning itself as a key player in the optical innovation landscape.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

17 Patents

#1,454 in Tokyo

#3,227 in Japan

#35,918 in the World

Tokyo, JP
Tokyo, Japan
Forward Citations = 103

10 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Crysoptix Kk. Retrieved from https://idiyas.com/company/crysoptix-kk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…